Peptide-Based Interactions with Calnexin Target Misassembled Membrane Proteins into Endoplasmic Reticulum-Derived Multilamellar Bodies

Journal of Molecular Biology

Volumn 378, Issue 2, 2008, Pages 337-352

  Korkhov, Vladimir M ^a   Milan Lobo, Laura ^a   Zuber, Benoît ^a   Farhan, Hesso ^a   Schmid, Johannes A ^b   Freissmuth, Michael ^a   Sitte, Harald H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

calnexin; G protein coupled receptors; GABA transporter 1; neurotransmitter transporters; transmembrane domains

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID CARRIER 1; CALNEXIN; GLUCOSIDASE; GLYCAN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; FLUORESCENCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

EID: 41249102584     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.02.056     Document Type: Article

References (56)

1. - neurotransmitter transporters. J. Neurochem. 71 (1998) 1785-1803
2. Gether U., Andersen P.H., Larsson O.M., and Schousboe A. Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27 (2006) 375-383
3. --dependent neurotransmitter transporters. Nature 437 (2005) 215-223
4. + symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol. Pharmacol. 70 (2006) 1630-1642
5. Sadlish H., and Skach W.R. Biogenesis of CFTR and other polytopic membrane proteins: new roles for the ribosome-translocon complex. J. Membr. Biol. 202 (2004) 115-126
6. Booth P.J., and High S. Polytopic membrane protein folding and assembly in vitro and in vivo. Mol. Membr. Biol. 21 (2004) 163-170
7. Kleizen B., and Braakman I. Protein folding and quality control in the endoplasmic reticulum. Curr. Opin. Cell. Biol. 16 (2004) 343-349
8. Dalbey R.E., and Chen M. Sec-translocase mediated membrane protein biogenesis. Biochim. Biophys. Acta 1694 (2004) 37-53
9. Nagamori S., Smirnova I.N., and Kaback H.R. Role of YidC in folding of polytopic membrane proteins. J. Cell Biol. 165 (2004) 53-62
10. Kuehn M.J., Schekman R., and Ljungdahl P.O. Amino acid permeases require COPII components and the ER resident membrane protein Shr3p for packaging into transport vesicles in vitro. J. Cell Biol. 135 (1996) 585-595
11. Kota J., and Ljungdahl P.O. Specialized membrane-localized chaperones prevent aggregation of polytopic proteins in the ER. J. Cell Biol. 168 (2005) 79-88
12. Tjoelker L.W., Seyfried C.E., Eddy Jr. R.L., Byers M.G., Shows T.B., Calderon J., et al. Human, mouse, and rat calnexin cDNA cloning: identification of potential calcium binding motifs and gene localization to human chromosome 5. Biochemistry 33 (1994) 3229-3236
13. de Virgilio C., Burckert N., Neuhaus J.M., Boller T., and Wiemken A. CNE1, a Saccharomyces cerevisiae homologue of the genes encoding mammalian calnexin and calreticulin. Yeast 9 (1993) 185-188
14. Hammond C., Braakman I., and Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc. Natl. Acad. Sci. USA 91 (1994) 913-917
15. Ellgaard L., and Frickel E.M. Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding. Cell. Biochem. Biophys. 39 (2003) 223-247
16. Molinari M., Calanca V., Galli C., Lucca P., and Paganetti P. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 299 (2003) 1397-1400
17. Swanton E., High S., and Woodman P. Role of calnexin in the glycan-independent quality control of proteolipid protein. EMBO J. 22 (2003) 2948-2958
18. Fontanini A., Chies R., Snapp E.L., Ferrarini M., Fabrizi G.M., and Brancolini C. Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-Tooth 1A Gas3/PMP22 mutants. J. Biol. Chem. 280 (2005) 2378-2387
19. Pind S., Riordan J.R., and Williams D.B. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269 (1994) 12784-12788
20. Le A., Steiner J.L., Ferrell G.A., Shaker J.C., and Sifers R.N. Association between calnexin and a secretion-incompetent variant of human alpha 1-antitrypsin. J. Biol. Chem. 269 (1994) 7514-7519
21. Pipe S.W., Morris J.A., Shah J., and Kaufman R.J. Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J. Biol. Chem. 273 (1998) 8537-8544
22. Kamhi-Nesher S., Shenkman M., Tolchinsky S., Fromm S.V., Ehrlich R., and Lederkremer G.Z. A novel quality control compartment derived from the endoplasmic reticulum. Mol. Biol. Cell. 12 (2001) 1711-1723
23. Spiliotis E.T., Pentcheva T., and Edidin M. Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules. Mol. Biol. Cell 13 (2002) 1566-1581
24. Okiyoneda T., Harada K., Takeya M., Yamahira K., Wada I., Shuto T., et al. Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol. Biol. Cell. 15 (2004) 563-574
25. Korkhov V.M., Farhan H., Freissmuth M., and Sitte H.H. Oligomerization of the γ-aminobutyric acid transporter-1 is driven by an interplay of polar and hydrophobic interactions in transmembrane helix II. J. Biol. Chem. 279 (2004) 55728-55736
26. Snapp E.L., Hegde R.S., Francolini M., Lombardo F., Colombo S., Pedrazzini E., et al. Formation of stacked ER cisternae by low affinity protein interactions. J. Cell Biol. 163 (2003) 257-269
27. Egan M.E., Glockner-Pagel J., Ambrose C., Cahill P.A., Pappoe L., Balamuth N., et al. Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8 (2002) 485-492
28. 2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells. Traffic 7 (2006) 562-573
29. Farhan H., Korkhov V.M., Paulitschke V., Dorostkar M.M., Scholze P., Kudlacek O., et al. Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1). J. Biol. Chem. 279 (2004) 28553-28563
30. Farhan H., Reiterer V., Korkhov V.M., Schmid J.A., Freissmuth M., and Sitte H.H. Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J. Biol. Chem. 282 (2007) 7679-7689
31. Zuber B., Haenni M., Ribeiro T., Minnig K., Lopes F., Moreillon P., and Dubochet J. Granular layer in the periplasmic space of gram-positive bacteria and fine structures of Enterococcus gallinarum and Streptococcus gordonii septa revealed by cryo-electron microscopy of vitreous sections. J. Bacteriol. 188 (2006) 6652-6660
32. Hammond C., and Helenius A. Folding of VSV G protein: sequential interaction with BiP and calnexin. Science 266 (1994) 456-458
33. Mathieu M.E., Grigera P.R., Helenius A., and Wagner R.R. Folding, unfolding, and refolding of the vesicular stomatitis virus glycoprotein. Biochemistry 35 (1996) 4084-4093
34. Groenendyk J., Zuppini A., Shore G., Opas M., Bleackley R.C., and Michalak M. Caspase 12 in calnexin-deficient cells. Biochemistry 45 (2006) 13219-13226
35. Free R.B., Hazelwood L.A., Cabrera D.M., Spalding H.N., Namkung Y., Rankin M.L., and Sibley D.R. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. J. Biol. Chem. 282 (2007) 21285-21300
36. Zhang J., Kang D.E., Xia W., Okochi M., Mori H., Selkoe D.J., and Koo E.H. Subcellular distribution and turnover of presenilins in transfected cells. J. Biol. Chem. 273 (1998) 12436-12442
37. Danilczyk U.G., and Williams D.B. The lectin chaperone calnexin utilizes polypeptide-based interactions to associate with many of its substrates in vivo. J. Biol. Chem. 276 (2001) 25532-25540
38. Wanamaker C.P., and Green W.N. N-Linked glycosylation is required for nicotinic receptor assembly but not for subunit associations with calnexin. J. Biol. Chem. 280 (2005) 33800-33810
39. Parodi A.J. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem. J. 348 (2000) 1-13
40. Schmid J.A., Scholze P., Kudlacek O., Freissmuth M., Singer E.A., and Sitte H.H. Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276 (2001) 3805-3810
41. --coupled neurotransmitter transporters. Eur. J. Pharmacol. 479 (2003) 229-236
42. Farhan H., Freissmuth M., and Sitte H.H. Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. Handb. Exp. Pharmacol. 175 (2006) 233-249
43. Korkhov V.M., Holy M., Freissmuth M., and Sitte H.H. The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle. J. Biol. Chem. 281 (2006) 13439-13448
44. Tate C.G., Whiteley E., and Betenbaugh M.J. Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter. J. Biol. Chem. 274 (1999) 17551-17558
45. Milojevic T., Reiterer V., Stefan E., Korkhov V.M., Dorostkar M.M., Ducza E., et al. The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol. Pharmacol. 69 (2006) 1083-1094
46. Ou W.J., Cameron P.H., Thomas D.Y., and Bergeron J.J. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364 (1993) 771-776
47. Zapun A., Darby N.J., Tessier D.C., Michalak M., Bergeron J.J., and Thomas D.Y. Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J. Biol. Chem. 273 (1998) 6009-6012
48. Ihara Y., Cohen-Doyle M.F., Saito Y., and Williams D.B. Calnexin discriminates between protein conformational states and functions as a molecular chaperone in vitro. Mol. Cell 4 (1999) 331-341
49. Liu Y., and Vollrath D. Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum. Mol. Genet. 13 (2004) 1193-1204
50. Fortun J., Li J., Go J., Fenstermaker A., Fletcher B.S., and Notterpek L. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J. Neurochem. 92 (2005) 1531-1541
51. Walker R.H., and Shashidharan P. Developments in the molecular biology of DYT1 dystonia. Mov. Disord. 18 (2003) 1102-1107
52. Kamimoto T., Shoji S., Hidvegi T., Mizushima N., Umebayashi K., Perlmutter D.H., and Yoshimori T. Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity. J. Biol. Chem. 281 (2006) 4467-4476
53. Mulugeta S., Nguyen V., Russo S.J., Muniswamy M., and Beers M.F. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am. J. Respir. Cell. Mol. Biol. 32 (2005) 521-530
54. Studer D., Graber W., Al-Amoudi A., and Eggli P. A new approach for cryofixation by high-pressure freezing. J. Microsc. 203 (2001) 285-294
55. Schmid J.A., and Sitte H.H. Fluorescence resonance energy transfer in the study of cancer pathways. Curr. Opin. Oncol. 15 (2003) 55-64
56. Xia Z., and Liu Y. Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. Biophys. J. 81 (2001) 2395-2402